Carolyn F. Deacon

Carolyn F. Deacon

Associate Professor


  1. 2005
  2. Published

    Neutral endopeptidase 24.11 and dipeptidyl peptidase IV are both mediators of the degradation of glucagon-like peptide 1 in the anaesthetised pig. / Plamboeck, A; Holst, Jens Juul; Carr, R D; Deacon, C F.

    In: Diabetologia, Vol. 48, No. 9, 09.2005, p. 1882-90.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes. / Meier, J J; Gallwitz, B; Askenas, M; Vollmer, K; Deacon, C F; Holst, Jens Juul; Schmidt, W E; Nauck, M A.

    In: Diabetologia, Vol. 48, No. 9, 09.2005, p. 1872-81.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed beta-cell function in patients with type 2 diabetes. / Mari, A; Sallas, W M; He, Y L; Watson, C; Ligueros-Saylan, M; Dunning, B E; Deacon, C F; Holst, Jens Juul; Foley, J E.

    In: The Journal of clinical endocrinology and metabolism, Vol. 90, No. 8, 08.2005, p. 4888-94.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors. / Holst, Jens Juul; Deacon, C F.

    In: Diabetologia, Vol. 48, No. 4, 04.2005, p. 612-5.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Enhanced glucagon-like peptide-1 (GLP-1) response to oral glucose in glucose-intolerant HIV-infected patients on antiretroviral therapy. / Andersen, O; Haugaard, S B; Holst, Jens Juul; Deacon, C F; Iversen, J; Andersen, U B; Nielsen, J O; Madsbad, S.

    In: HIV Medicine, Vol. 6, No. 2, 03.2005, p. 91-8.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Dipeptidyl peptidase IV inhibitors: a promising new therapeutic approach for the management of type 2 diabetes. / Deacon, Carolyn F; Holst, Jens J.

    In: International Journal of Biochemistry & Cell Biology, Vol. 38, No. 5-6, 2005, p. 831-44.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Enhanced glucagon-like peptide- 1 (GLP-1) response to oral glucose in glucose intolerant HIV-infected patients on antiretroviral therapy. / Andersen, O.; Haugaard, S.B.; Holst, Jens Juul; Deacon, Carolyn F.; Iversen, J.; Andersen, U.B.; Nielsen, J.O.; Madsbad, S.

    In: HIV Medicine, Vol. 6, 2005, p. 91-98.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    For debate: Are antidiabetic actions of DPP-IV inhibitors mediated by glucagon-like peptide- 1? / Holst, Jens Juul; Deacon, Carolyn F.

    In: Diabetologia, No. 48, 2005, p. 612-615.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Glucagon-like peptide-1 mediates the therapeutic actions of Dpp-IV inhibitors. / Holst, Jens Juul; Deacon, Carolyn F.

    In: Diabetologia, No. 48, 2005, p. 612-615.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Insulinotropic effect of gastric inhibitory polypeptide (GIP) in women with a history of gestational diabetes. / Meier, J.J.; Gallwitz, B.; Askenas, M.; Vollmer, K.; Deacon, C.F.; Holst, J.J.; Schmidt, W.E.; Nauck, M.A.

    In: Diabetologia, No. 48, 2005, p. 1872-1881.

    Research output: Contribution to journalJournal articleResearch

Previous 1 2 Next

ID: 9220